Pharmacovigilance: a responsibility shared or someone else’s problem? lessons from nimesulide.
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Poster
- By: HENMAN, Martin (Trinity College Dublin, Dublin, Ireland)
Suspension of a drug's Marketing Authorisation because of serious adverse drug reactions (ADRs) has tragic consequences for patients and it raises questions concerning the protection of public health. Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) authorised for the relief of the symptoms of osteoarthritis, dental pain and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.